Statement of collaboration between Mirador Global e-Projection
Tokyo, Japan, March 23, 2022 — Mirador Global LP (hereinafter “Mirador”) and e-Projection K.K. (hereinafter “e-Projection”), speciality consultancies based in Philadelphia, PMA, USA and Tokyo, Japan, respectively, today announced a partnership to develop expanded outreach to mutual markets. The partnership will allow both parties to promote businesses to geographies previously unreached, and to mutually share each party’s robust capabilities.
Through this partnership, e-Projection will be able to promote its business to North America and the EU, and Mirador will be able to do so to Japan. Both parties will engage in joint activities in order to serve their clients in a truly global context, including global research projects and global sales forecasting models.
“We are excited by this opportunity to partner with e-Projection Japan gaining access to their deep experience and expertise in this critical market enabling us to provide truly global strategic consulting service to our clients. In turn we look forward to collaborating with this talented team to support the generation of clear, robust US and EU insights- based strategies for their Japanese client base” – Lizzie Grosset, Vice President Global Access Strategy, Mirador
“We have been impressed by the skills and capabilities of the experts at Mirador in the last few years and are thrilled to formalize our partnership with this great company. With this collaboration, we would be able to offer/ develop global insights and strategies that are penetrating and actionable to our Japanese customer base, and at the same time, would be able to help the biotech community across the globe with cutting edge findings from the Japanese market.” – Tosh Nagate, CEO, e-Projection.
e-Projection is a Tokyo-based consulting firm dedicated to global biotech, pharma, investors and academic institutions who are interested in bringing their products/technologies to the Japanese market. e-Projection is a one-stop-shop consultancy which covers all the necessary factors for a non-Japanese biotech/pharmaceutical to plan to enter the Japanese market.
To learn more about e-Projection, visit http://e-projection.com/
About Mirador Global
Part of the Coeus Holdings Family, Mirador provides expertise in early commercial development for global and US domestic drug commercialization and market access efforts. Our consultants have many years in both client and consulting roles, spanning skill sets and US, European and LAtam geographies which enables us to understand our customers’ objectives and develop clear, actionable and robust solutions to maximize the commercial potential of their assets.
To learn more about Mirador Global, www.miradorglobal.com and www.coeusholdings.com